Nazrul Islam

Associate Professor Nazrul Islam is affiliated with the School of Clinical Sciences, Pharmacy Department at Queensland University of Technology (QUT). His research focuses on pulmonary drug delivery systems, nanotechnology-driven drug formulations, and biodegradable polymer-based controlled-release micro/nanoparticles for respiratory applications. He holds editorial roles in journals like the International Journal of Biomacromolecules and has authored a book on lung-targeted drug delivery systems.

His key research grants include King Khalid University funding (2020), Indonesian Government support (2017/19), and multiple IHBI grants (Australia). Teaching expertise spans pharmaceutics, drug formulation, and respiratory drug delivery.

Recent work emphasizes inhalable antibiotic-loaded nanoparticles for combating antibiotic-resistant infections, with 2025 publications on biofilm-targeting therapies and ceftriaxone liposomal formulations. His 2024 studies highlight challenges in inhalable ciprofloxacin formulations and lipid-polymer hybrid nanoparticles for lung cancer treatment.

Supervision includes PhD topics like DPI formulation development and chitosan nanoparticle lung delivery. Grant review experience spans Hong Kong, Canada, and NHMRC programs.